Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04610749
Other study ID # S-20200050
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 25, 2020
Est. completion date February 25, 2022

Study information

Verified date April 2022
Source Region of Southern Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In recent years damage to the nerve fibers in the retina has been experienced as an early sign of complications resulting from type 2 diabetes. In addition, it has been presented that people with type 2 diabetes are at increased risk of developing brain diseases, such as mild memory impairment and Alzheimer's disease, as well as mental illness in the form of depression. The eye corresponds to be a protruding part of the brain which means the brain and the eye share common features. Currently it is time and cost consuming to asses changes in the brain, but recent research has shown that patient friendly eye examinations can detect nerve loss brain diseases. Recent studies have shown that depression can also have a physiological component, which can be measured by changes in structures in the retina of the eye. In this research project, we will conduct a clinical study, to assess whether there is an association between changes in the retina of the eye (e.g. vascular structure, retinal thickness and oxygen saturation) and mild memory impairment and depression respectively in people with type 2 diabetes. The clinical study will help to clarify the possibility of including patient-friendly eye examinations in the assessment of minimal memory impairment and depression in patients with type 2 diabetes. 200 people with type 2 diabetes will be invited to participate in a clinical cross-sectional study. The Funen Diabetes Database will be used as recruitment tool. Participants will undergo a thorough eye examination as well as neuropsychological examinations for signs of mild memory impairment. They will also complete questionnaires regarding depressive symptoms. Overall, the research project will help to create awareness in this area among both healthcare professionals and patients. Early risk detection could mean better diabetes care and fewer complications, which will have a major impact on quality of life and contribute to socio-economic gains. Any findings may contribute to the discussion of individualized screening and treatment if some individuals within this group are at increased risk of developing memory impairment or depression.


Description:

A cross sectional study will be performed to determine correlation between retinal endpoints in persons with type 2 diabetes and cognitive impairment. 200 patients with type 2 diabetes without diabetic retinopathy and non to severe diabetic retinopathy. Primary objective: To determine whether structural and/or metabolic retinal markers are able to differentiate people with minimal cognitive impairment (MCI) within persons with type 2 diabetes (T2D). Secondary objective 1. To assess whether retinal metabolism measured by oximetry can identify individuals with MCI among people with T2D. 2. To assess whether retinal metabolism measured by oximetry can identify individuals with depressive symptoms among people with T2D. 3. To determine whether retinal structural markers can identify people with depressive symptoms among people with T2D.


Recruitment information / eligibility

Status Completed
Enrollment 148
Est. completion date February 25, 2022
Est. primary completion date February 25, 2022
Accepts healthy volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: 1. Type 2 diabetes 2. 65 years and older 3. Diabetes duration of at least 5 years 4. None to severe non-proliferative DR (NPDR), as determined by the evaluating ophthalmologists using fundus examination by slit-lamp biomicroscopy or fundus imaging. 5. Able to provide informed consent Exclusion Criteria: 1. Previous history of stroke or neurodegenerative diseases. 2. Proliferative DR (PDR), Diabetic Macular Edema (DME) or other eye disorders affecting vision besides these complications of DR. 3. Previous laser photocoagulation. 4. Other diseases which may induce retinal neurodegeneration (e.g. glaucoma). 5. Subjects with a refractive error = ± 6 D. 6. Media opacities that preclude retinal imaging. 7. Severe systemic illness or personal circumstances that would not make it possible for the patients to fulfil study protocols.

Study Design


Locations

Country Name City State
Denmark Odense University Hospital Odense Fyn

Sponsors (1)

Lead Sponsor Collaborator
Region of Southern Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Retinal metabolism Measured by retinal oximetry 1 day
Secondary Retinal neurodegeneration Measured by Spectral Domain Optical Coherence Tomography 1 day
Secondary Central Retinal vascular abnormalities Measured by fundus photography and analyzed with semi automated software 1 day
Secondary Retinal vascular abnormalities Measured by Optical Coherence Tomography Angiography 1 day
Secondary Depressive symptoms Measured by Geriatric depression scale GDS-15 and Measured by Inventory of depressive symptomatology (Self-report) 1 day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A